Overview
McKusick-Kaufman syndrome (MKKS), also known as hydrometrocolpos-polydactyly syndrome, is a rare autosomal recessive genetic disorder characterized by a triad of congenital anomalies: hydrometrocolpos (accumulation of fluid in the vagina and uterus in females), postaxial polydactyly (extra fingers or toes on the outer side of the hands or feet), and congenital heart defects. The condition is caused by mutations in the MKKS gene (also called BBS6), located on chromosome 20p12, which encodes a protein involved in protein processing and folding (a chaperonin-like protein). The syndrome primarily affects the reproductive, skeletal, and cardiovascular systems. In females, hydrometrocolpos is often the presenting feature at birth and can cause abdominal distension, urinary obstruction, and bowel compression. In males, genital anomalies may include hypospadias, prominent scrotal raphe, or cryptorchidism, though the phenotype is generally less distinctive. Congenital heart defects are variable and may include atrioventricular canal defects, atrial septal defects, or other structural cardiac malformations. Postaxial polydactyly may affect one or more limbs and can range from a small skin tag to a fully formed extra digit. McKusick-Kaufman syndrome was initially described in the Old Order Amish population, where it occurs with higher frequency due to a founder effect. It is important to distinguish MKKS from Bardet-Biedl syndrome (BBS), as mutations in the same MKKS/BBS6 gene can cause both conditions, and some features overlap. Children initially diagnosed with MKKS should be monitored for additional features of BBS, such as obesity, retinal dystrophy, renal anomalies, and learning difficulties, which may emerge later in childhood. Treatment is primarily surgical and supportive, including drainage or surgical correction of hydrometrocolpos, removal of extra digits, and repair of congenital heart defects as needed. With appropriate management, the prognosis is generally favorable.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for McKusick-Kaufman syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for McKusick-Kaufman syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for McKusick-Kaufman syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to McKusick-Kaufman syndrome.
Community
No community posts yet. Be the first to share your experience with McKusick-Kaufman syndrome.
Start the conversation →Latest news about McKusick-Kaufman syndrome
No recent news articles for McKusick-Kaufman syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about McKusick-Kaufman syndrome
What is McKusick-Kaufman syndrome?
McKusick-Kaufman syndrome (MKKS), also known as hydrometrocolpos-polydactyly syndrome, is a rare autosomal recessive genetic disorder characterized by a triad of congenital anomalies: hydrometrocolpos (accumulation of fluid in the vagina and uterus in females), postaxial polydactyly (extra fingers or toes on the outer side of the hands or feet), and congenital heart defects. The condition is caused by mutations in the MKKS gene (also called BBS6), located on chromosome 20p12, which encodes a protein involved in protein processing and folding (a chaperonin-like protein). The syndrome primarily
How is McKusick-Kaufman syndrome inherited?
McKusick-Kaufman syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does McKusick-Kaufman syndrome typically begin?
Typical onset of McKusick-Kaufman syndrome is neonatal. Age of onset can vary across affected individuals.